THC: One Molecule, One Receptor, One Number

The receptor does the work

Delta-9-tetrahydrocannabinol has one main molecular target, and that target has a name: CB1. Matsuda and colleagues published the structure of this cannabinoid receptor in 1990, along with functional expression of the cloned cDNA [2]. CB1 is not parked in one small corner of the body. Its distribution across the central nervous system is wide [2]. Start with the receptor, and everything else about this molecule falls into place.

THC is the short form. Delta-9-tetrahydrocannabinol is the full one, and it is the intoxicating compound of the plant, a trait that sets it apart from every other cannabinoid catalogued so far, as the 1964 work of Gaoni and Mechoulam first established when they isolated the active constituent of hashish [1]. Cibdol sells no THC products. Worth saying early, because what follows is chemistry and paperwork rather than a product pitch.

Centuries of use, no named molecule

Cannabis was not new in 1964. Centuries of use sit behind it, plus a long shelf of written accounts. What nobody had was the link between an effect and a specific named molecule [1]. Gaoni and Mechoulam closed that gap with three pieces of work in a single paper: isolation, structure, and partial synthesis [1].

The paper trail, year by year

From olivetolate to two kinds of crop

What a batch certificate puts in writing

Most studied, least relevant here

THC holds a clear rank in cannabinoid research. It is the most studied of the lot. It is also the compound with the least bearing on how Cibdol formulates and produces anything. Both things are true at once, which is exactly why a hemp company bothers to write a page about a molecule it does not sell. People ask. The chemistry is public. So here it is, in order.

The 1990 receptor paper set off something its authors could not have fully planned [2]. Once a cannabinoid receptor existed as a described protein, the next question was obvious: what does the body itself send to it. The research that followed named two internal signalling compounds, anandamide and 2-AG, along with the system they belong to [2].

A plant molecule that opened a human map

That is the strange shape of this timeline. A compound pulled out of hashish in 1964 [1] led to a receptor structure in 1990 [2], and the receptor led straight back to molecules the body makes on its own [2]. The plant arrived first in the laboratory. The system had been there the whole time. For hemp work, the trail stops one step earlier, at cannabigerolic acid [3].

Two questions with paper answers

Where the 0.03% comes from

From a measurement, not from a marketing decision. The strongest oil in our range carries a measured THC figure of 0.03%, and it appears in print because a laboratory produced that value. Genetics set the ceiling long before the analysis, since the route taken after cannabigerolic acid depends on the variety [3]. Industrial hemp sits on one side of that split, drug-type cannabis on the other [3]. A certificate reports the result of the crop and the process behind it.

Which report belongs to which bottle

Every Cibdol CBD product has its own batch certificate, and that certificate is tied to a batch rather than to a product name in general. So the number worth reading is the one attached to the item in your hand. One product, one report, one date on it. Check it before the bottle joins your routine. Working with cannabinoids since 2014 has taught us one thing above all others: claims are cheap, measured values are not.